The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Northern RNA Inc.
Calgary, Canada
A
11-50 Employees
-
Key takeaway
The company specializes in the end-to-end supply of nucleic acid products, including mRNA, which is directly relevant to RNA sequencing. Their expertise in GMP-grade manufacturing and scalable production supports innovation in the development of life-enabling therapies.
Reference
Service
SERVICES | Northern RNA
Rna Diagnostics
Old Toronto, Canada
A
11-50 Employees
2010
Key takeaway
RNA Diagnostics focuses on cancer diagnostics and utilizes its RNA Disruption Assay™ (RDA™) to evaluate patient responses to cancer therapy. This innovative approach promises real-time monitoring, enhancing personalized medicine and treatment management for cancer patients.
Reference
Core business
RNA Diagnostics | A Real Time Cancer Therapy Guidance Tool
RJH Biosciences
Edmonton, Canada
A
11-50 Employees
2016
Key takeaway
RJH Biosciences specializes in developing transfection reagents and delivery systems for various nucleic acids, including siRNA and mRNA, which are essential for RNA sequencing applications. Their focus on innovative drug delivery systems and R&D services supports the effective transport of nucleic acid therapeutics in both research and clinical settings.
Reference
Product
siRNA, microRNA and ASO Delivery - RJH BioSciences
Transient transfection with short oligonucleotides Attachment dependent and independent cells Stem, and primary cells
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Ladder Therapeutics
Old Toronto, Canada
A
1-10 Employees
2021
Key takeaway
Serna Bio is focused on RNA-targeted drug discovery, using an AI-enabled, data-first approach to define RNA-small molecule interactions. Their Discovery Platform is dedicated to developing small molecule programs that target non-coding RNA and undruggable proteins, contributing to the emerging field of RNA therapeutics.
Reference
Core business
AI Enabled RNA Drug Discovery | Serna Bio
At Serna Bio we are using an AI enabled, data-first approach to write the rules that define RNA-small molecule interactions. Our Discovery Platform powers our first-in-class small molecule programs targeted at classically undruggable proteins and non-coding RNA targets, targeting both human and non-human biology.
Environmental Bio Detection Products Inc
Mississauga, Canada
A
1-10 Employees
1992
Key takeaway
The company, EBPI, offers a comprehensive range of genotoxicity and mutagenicity tests, including advanced technologies like quantitative polymerase chain reaction (qPCR) and next-generation sequencing (NGS), which are essential for detecting DNA damage and characterizing genetic material.
Reference
Service
DNA Analysis and Characterization
Sequence Bio
St. John's, Canada
A
51-100 Employees
2013
Key takeaway
Sequence Bio is leveraging a systems biology approach that includes multi-omics and real-world patient data to enhance drug target discovery. Their commitment to genomics research, exemplified by the NL Genome Project, aims to improve health outcomes through innovative methodologies.
Reference
Core business
Sequence Bio
eDNAtec Inc
Canada
A
1-10 Employees
2014
Key takeaway
eDNAtec emphasizes the significance of their eDNA collection methods, which provide a minimally invasive alternative to traditional sampling techniques. This approach is crucial for understanding marine biodiversity, directly linking to the importance of RNA sequencing in ecological research and conservation efforts.
Reference
Product
Our Science | eDNAtec
Understanding marine biodiversity is paramount to environmental stewardship and the sustainability of ocean-related activities.
Aurora Biomed
Vancouver, Canada
A
11-50 Employees
1990
Key takeaway
Aurora Biomed is dedicated to enhancing research efficiency in the life sciences, particularly through its VERSA 2100 platform, which enables high-throughput preparation of nucleic acid sequences, thereby improving mRNA production efficiency. Their commitment to automation solutions supports advancements in molecular diagnostics and precision medicine.
Reference
Product
mRNA vaccine upstream automated processing system - Aurora Biomed
VERSA 2100 provides high-throughput preparation of nucleic acid sequences, improving mRNA production efficiency.
DNAstack
Old Toronto, Canada
A
11-50 Employees
2014
Key takeaway
The company emphasizes its role in enabling breakthroughs in genomics and health through the federated sharing and analysis of genomic data, which is highly relevant to RNA sequencing. Their focus on AI-powered discoveries suggests a commitment to advancing genomic research and collaboration.
Reference
Core business
DNAstack
We enable breakthrough discoveries through federated sharing and analysis of genomic, clinical, and biomedical data.
Fusion Genomics Corporation
Burnaby, Canada
A
11-50 Employees
2013
Key takeaway
Fusion Genomics Corp. focuses on transformative testing for infectious diseases, which may involve advanced techniques like RNA sequencing.
Reference
Core business
Fusion Genomics Corp. | The DNA Diagnosis Company
Technologies which have been searched by others and may be interesting for you:
In the RNA sequencing industry in Canada, several key considerations are essential for thorough research. First, understanding the regulatory landscape is crucial, as Health Canada and other agencies oversee compliance and safety standards for genomic technologies. This impacts how companies operate and innovate within the sector. Additionally, the competitive landscape is significant, with various players ranging from established biotech firms to emerging startups, each contributing to advancements in RNA sequencing technologies. Furthermore, the industry benefits from a robust academic and research community, which fosters collaboration and innovation. However, challenges such as high operational costs and the need for skilled labor can pose barriers to entry for new companies. Environmental concerns related to waste management and the sustainability of laboratory practices are also gaining attention, making it vital for companies to adopt eco-friendly protocols. Opportunities abound, especially with the increasing demand for personalized medicine and the potential for RNA sequencing in drug discovery and diagnostics. Canada’s strong healthcare system and investment in biotechnology research create a favorable environment for growth. Lastly, the global market relevance of RNA sequencing cannot be overlooked, as Canada plays a critical role in international research collaborations and technology exchanges, positioning itself as a key player in the global landscape of genomic sequencing.
Some interesting numbers and facts about your company results for RNA Sequencing
| Country with most fitting companies | Canada |
| Amount of fitting manufacturers | 173 |
| Amount of suitable service providers | 172 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1990 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for RNA Sequencing
What are related technologies to RNA Sequencing?
Based on our calculations related technologies to RNA Sequencing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of RNA Sequencing?
Start-Ups who are working in RNA Sequencing are Ladder Therapeutics
Which industries are mostly working on RNA Sequencing?
The most represented industries which are working in RNA Sequencing are Biotechnology, IT, Software and Services, Other, Research, Medical
How does ensun find these RNA Sequencing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
